Spine Metastases Clinical Trials

10 recruiting

Spine Metastases Trials at a Glance

11 actively recruiting trials for spine metastases are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Miami, Boston, and Cleveland. Lead sponsors running spine metastases studies include Baptist Health South Florida, Case Comprehensive Cancer Center, and Cancer Trials Ireland.

Browse spine metastases trials by phase

Treatments under study

About Spine Metastases Clinical Trials

Looking for clinical trials for Spine Metastases? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Spine Metastases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Spine Metastases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting

Effectiveness Of Radiofrequency Ablation And Stabilization In Metastatic Spine Lesions By Positron Emission Computed Tomography (PET-CT) Confirmation

Spine MetastasesRadiofrequency AblationBone Cancer Metastatic+1 more
National and Kapodistrian University of Athens16 enrolled1 locationNCT06716294
Recruiting
Phase 2

Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

Spine MetastasesSpine Stereotactic Radiosurgery (sSRS)
Case Comprehensive Cancer Center130 enrolled1 locationNCT04218617
Recruiting
Phase 1Phase 2

Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

Spine Metastases
Baptist Health South Florida74 enrolled1 locationNCT05534321
Recruiting

Spine Oncology Registry

Spine MetastasesSpine TumorSpine Cancer
Ohio State University Comprehensive Cancer Center3,000 enrolled3 locationsNCT07225491
Recruiting
Not Applicable

Radiofrequency Ablation/Bone Augmentation + Radiotherapy vs Radiotherapy Alone

Spine MetastasesBone Pain
University of Minnesota36 enrolled1 locationNCT07090122
Recruiting
Not Applicable

Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column

Spine MetastasesMetastasis Spine
Baptist Health South Florida60 enrolled1 locationNCT04802603
Recruiting
Not Applicable

Stereotactic Magnetic Resonance Guided Radiation Therapy

Prostate CancerLung CancerSpine Metastases+10 more
Dana-Farber Cancer Institute397 enrolled2 locationsNCT04115254
Recruiting
Phase 2

Definitive Radiation for High-Risk Spine Metastases

Metastatic Breast CancerMetastatic CancerMetastatic Lung Cancer+5 more
Stony Brook University26 enrolled1 locationNCT06165419
Recruiting
Phase 1Phase 2

Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases

Solid Tumor Spine Metastases
Cancer Trials Ireland126 enrolled3 locationsNCT06078813
Recruiting
Not Applicable

Increased Early Pain Relief by Adding Vertebroplasty to SBRT

PainSpine MetastasesRadiation Therapy
Centre hospitalier de l'Université de Montréal (CHUM)50 enrolled2 locationsNCT05317026
Recruiting
Not Applicable

Post Operative RT for Limited Spine Metastases

Spine Metastases
National Taiwan University Hospital111 enrolled1 locationNCT05495399